Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke

Cellular and Molecular Neurobiology

Volumn 32, Issue 3, 2012, Pages 319-336

  Srivastava, Kirtiman ^a   Bath, Philip M W ^a   Bayraktutan, Ulvi ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

eNOS; Ischaemia; NO; Oxidative stress; Therapeutic strategies

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; ELLAGIC ACID; ENALAPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; MANIDIPINE; NIFEDIPINE; NITRIC OXIDE DONOR; PHOSPHODIESTERASE III INHIBITOR; PIOGLITAZONE; RAMIPRIL; RESVERATROL; S NITROSOGLUTATHIONE; SILDENAFIL; SIMVASTATIN; TELMISARTAN; TETRAHYDROBIOPTERIN; TRANDOLAPRIL; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZJM 289;

ASTROCYTE; BRAIN INFARCTION; BRAIN ISCHEMIA; CLAUDICATION; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; LIMB ISCHEMIA; LOW DRUG DOSE; MICROGLIA; MOLECULAR PATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROKE; VASCULITIS;

ANIMALS; BRAIN ISCHEMIA; HUMANS; NEURAL PATHWAYS; NITRIC OXIDE SYNTHASE TYPE III; STROKE; UP-REGULATION;

EID: 84859921204     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-011-9777-z     Document Type: Review

References (203)

1. Aktas B, Utz A, Hoenig-Liedl P, Walter U, Geiger J (2003) Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies. Stroke 34:764-769 (Pubitemid 36307408)
2. Allen C, Bayraktutan U (2008) Risk factors for ischaemic stroke. Int J Stroke 3:105-116 (Pubitemid 351566844)
3. Allen C, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4:461-470
4. Amin-Hanjani S, Stagliano NE, Yamada M, Huang PL, Liao JK, Moskowitz MA (2001) Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32:980-986
5. Andrew PJ, Mayer B (1999) Enzymatic function of nitric oxide synthases. Cardiovasc Res 43:521-531 (Pubitemid 29369251)
6. Aoki C, Nakano A, Tanaka S, Yanagi K, Ohta S, Jojima T, Kasai K, Takekawa H, Hirata K, Hattori Y (2010) Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol [Epub ahead of print]
7. Askalan R, Deveber G, Ho M, Ma J, Hawkins C (2006) Astrocytic-inducible nitric oxide synthase in the ischemic developing human brain. Pediatr Res 60:687-692 (Pubitemid 44789510)
8. Awtry EH, Loscalzo J (2000) Aspirin. Circulation 101:1206-1218 (Pubitemid 30146625)
9. Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM (2009) Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med 151:861-871
10. Bath PM, Gray LJ (2005) Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 330:342
11. Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R, for the PRoFESS Study Group (2009) Effect of telmisartan on functional outcome, recurrence, and BP in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke 40:3541-3546
12. Beasley TC, Bari F, Thore C, Thrikawala N, Louis T, Busija D (1998) Cerebral ischemia/reperfusion increases endothelial nitric oxide synthase levels by an indomethacin-sensitive mechanism. J Cereb Blood Flow Metab 18:88-96 (Pubitemid 28019015)
13. Beckman JS (1991) The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15:53-59
14. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A (2002) Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 277:6214-6222 (Pubitemid 34968412)
15. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ, CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706-1717
16. Birnbaum Y, Ashitkov T, Uretsky BF, Ballinger S, Motamedi M (2003) Reduction of infarct size by short-term pretreatment with atorvastatin. Cardiovasc Drugs Ther 17:25-30 (Pubitemid 36898095)
17. Bolaños JP, Almeida A (1999) Roles of nitric oxide in brain hypoxia-ischemia. Biochim Biophys Acta 1411:415-436 (Pubitemid 29221965)
18. Bulckaen H, Prévost G, Boulanger E, Robitaille G, Roquet V, Gaxatte C, Garçon G, Corman B, Gosset P, Shirali P, Creusy C, Puisieux F (2008) Low-dose aspirin prevents age-related endothelial dysfunction in a mouse model of physiological aging. Am J Physiol Heart Circ Physiol 294:H1562-H1570 (Pubitemid 351490585)
19. Butterworth RJ, Cluckie A, Jackson SH, Buxton-Thomas M, Bath PM (1998) Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 8:158-165 (Pubitemid 28192817)
20. Cai W, Zhu Y, Furuya K, Li Z, Sokabe M, Chen L (2008) Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 55:127-138
21. Cargnoni A, Comini L, Bernocchi P, Bachetti T, Ceconi C, Curello S, Ferrari R (2001) Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril. Br J Pharmacol 133:145-153 (Pubitemid 32500461)
22. Carolei A, Prencipe M, Fiorelli M, Fieschi C (1986) Severity of stroke and aspirin. Neurology 36:1010-1011 (Pubitemid 16098254)
23. Castillo J, Leira R, Moro MA, Lizasoain I, Serena J, Dávalos A (2003) Neuroprotective effects of aspirin in patients with acute cerebral infarction. Neurosci Lett 339:248-250 (Pubitemid 36299011)
24. Chavakis E, Dernbach E, Hermann C, Mondorf U, Zeiher A, Dimmeler S (2001) Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 103:2102-2107 (Pubitemid 32373015)
25. Chen XN, Xu J, Feng Z, Fan M, Han JY, Yang Z (2010) Simvastatin combined with nifedipine enhances endothelial cell protection by inhibiting ROS generation and activating Akt phosphorylation. Acta Pharmacol Sin 31:813-820
26. Cimino M, Balduini W, Carloni S, Gelosa P, Guerrini U, Tremoli E, Sironi L (2005) Neuroprotective effect of simvastatin in stroke: a comparison between adult and neonatal rat models of cerebral ischemia. Neurotoxicology 26:929-933 (Pubitemid 41427533)
27. Cox MW, Fu W, Chai H, Paladugu R, Lin PH, Lumsden AB, Yao Q, Chen C (2005) Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J Surg Res 124:104-111 (Pubitemid 40269809)
28. Das S, Maulik N, Das DK, Kadowitz PJ, Bivalacqua TJ (2002) Cardioprotection with sildenafil, a selective inhibitor of cyclic 30, 5′-monophosphate-specific phosphodiesterase 5. Drugs Exp Clin Res 28:213-219 (Pubitemid 36596885)
29. Datar R, Kaesemeyer WH, Chandra S, Fulton DJ, Caldwell RW (2010) Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx. Br J Pharmacol 160:1765-1772
30. De Cristóbal J, Cárdenas A, Lizasoain I, Leza JC, Fernández-Tomé P, Lorenzo P, Moro MA (2002) Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke 33:261-267 (Pubitemid 34052222)
31. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95-112 (Pubitemid 30056398)
32. Demirci B, McKeown PP, Bayraktutan U (2005) Blockade of angiotensin II provides additional benefits in hypertension- and ageing-related cardiac and vascular dysfunctions beyond its BP-lowering effects. J Hypertens 23:2219-2227 (Pubitemid 41666752)
33. Dhein S, Salameh A, Berkels R, Klaus W (1999) Dual mode of action of dihydropyridine calcium antagonists: a role for nitric oxide. Drugs 58:397-404 (Pubitemid 29427851)
34. Die J, Wang K, Fan L, Jiang Y, Shi Z (2010) Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions. Brain Res 1346:251-261
35. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A (1996) European stroke prevention study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143:1-13 (Pubitemid 26402780)
36. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ, MATCH investigators (2004) Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364:331-337
37. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-605
38. Ding Y, Vaziri ND (1998) Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 32:718-723 (Pubitemid 28480550)
39. Dong Q, Yang Y, Song L, Qian H, Xu Z (2010) Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating amp-activated protein kinase. Int J Cardiol 153:311-316
40. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, MokánM, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive investigators (2005) Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366:1279-1289 (Pubitemid 41416583)
41. Dorrepaal CA, van Bel F, Moison RM, Shadid M, van de Bor M, Steendijk P, Berger HM (1997) Oxidative stress during post-hypoxic-ischemic reperfusion in the newborn lamb: the effect of nitric oxide synthesis inhibition. Pediatr Res 41:321-326 (Pubitemid 27097896)
42. Dupuis F, Vincent JM, Limiñana P, Chillon JM, Capdeville-Atkinson C, Atkinson J (2010) Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat. J Hypertens 28:1566-1573
43. Edderkaoui M, Odinokova I, Ohno I, Gukovsky I, Go V, Pandol S, Gukovskaya A (2008) Ellagic acid induces apoptosis through inhibition of nuclear factor kappa B in pancreatic cancer cells. World J Gastroenterol 14:3672-3680
44. Endoh M, Maiese K, Wagner J (1994) Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 651:92-100 (Pubitemid 24222853)
45. Evans M, Roberts A, Davies S, Rees A (2004) Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Drugs 64:1181-1196 (Pubitemid 38858287)
46. Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW (2004) Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Biochem Pharmacol 67:1559-1567 (Pubitemid 38388218)
47. Ferrero ME, Bertelli AE, Fulgenzi A, Pellegatta F, Corsi MM, Bonfrate M, Ferrara F, De Caterina R, Giovannini L, Bertelli A (1998) Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am J Clin Nutr 68:1208-1214 (Pubitemid 28550950)
48. Flavin MP, Coughlin K, Ho LT (1997) Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience 80:437-448 (Pubitemid 27334593)
49. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R (2001) Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 88:E68-E75
50. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399:597-601
51. Gajkowska B, Mossakowski MJ (1997) Endothelial nitric oxide synthase in vascular endothelium of rat hippocampus after ischemia: evidence and significance. Folia Neuropathol 35: 171-180 (Pubitemid 127533692)
52. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, Chilian WM, Zhang C (2007) TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 27:1269-1275 (Pubitemid 46809414)
53. Geary GG, Krause DN, Duckles SP (1998) Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol 275:H292-H300
54. Gehrmann J, Matsumoto Y, Kreutzberg GW (1995) Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev 20:269-287
55. Gertz K, Laufs U, Lindauer U, Nickenig G, Böhm M, Dirnagl U, Endres M (2003) Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34:551-557 (Pubitemid 36206363)
56. Gibson CL, Murphy SP (2004) Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab 24:805-813 (Pubitemid 38880226)
57. Gibson CL, Constantin D, Prior MJ, Bath PM, Murphy SP (2005) Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 193:522-530 (Pubitemid 40616199)
58. González G, Alvarado-Vasquez N, Fernández-G JM, Cruz-Robles D, Del Valle L, Pinzón E, Torres I, Rodriguez E, Zapata E, Gómez-Vidales V, Montaño LF, de la Peña A (2010) The antithrombotic effect of the aminoestrogen prolame (N-(3-hydroxy-1, 3, 5(10)-estratrien-17B-YL)-3-hydroxypropylamine) is linked to an increase in nitric oxide production by platelets and endothelial cells. Atherosclerosis 208:62-68
59. Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274:1383-1385 (Pubitemid 26391464)
60. Guix FX, Uribesalgo I, Coma M, Muñoz FJ (2005) The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76:126-152 (Pubitemid 41242885)
61. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A, ESPRIT Study Group (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 367:1665-1673
62. Hankey GJ, Johnston SC, Easton JD, Hacke W, Mas JL, Brennan D, Mak KH, Bhatt DL, Fox KA, Topol EJ, CHARISMA Trial Investigators (2011) Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. Int J Stroke 6:3-9
63. Harker LA, Kadatz RA (1983) Mechanism of action of dipyridamole. Thromb Res Suppl 4:39-46 (Pubitemid 13078094)
64. Harris MB, Ju H, Venema VJ, Liang H, Zou R, Michell BJ, Chen ZP, Kemp BE, Venema RC (2001) Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J Biol Chem 276:16587-16591
65. Hashimoto A, Miyakoda G, Hirose Y, Mori T (2006) Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism. Atherosclerosis 189:350-357 (Pubitemid 44634499)
66. Hataji K, Watanabe T, Oowada S, Nagaya M, Kamibayashi M, Murakami E, Kawakami H, Ishiuchi A, Kumai T, Nakano H, Kobayashi S, Otsubo T (2010) Effects of a calcium-channel blocker (CV159) on hepatic ischemia/reperfusion injury in rats: evaluation with selective NO/pO2 electrodes and an electron paramagnetic resonance spin-trapping method. Biol Pharm Bull 33:77-83
67. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185 (Pubitemid 41043883)
68. Haynes MP, Li L, Sinha D, Russell KS, Hisamoto K, Baron R, Collinge M, Sessa WC, Bender JR (2003) Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J Biol Chem 278:2118-2123 (Pubitemid 36801275)
69. Haynes RL, Folkerth RD, Trachtenberg FL, Volpe JJ, Kinney HC (2009) Nitrosative stress and inducible nitric oxide synthase expression in periventricular leukomalacia. Acta Neuropathol 118:391-399
70. He Y, Yan J-t, Tu R-h, Wang P-h, Wang D-w (2006) Effects of thiazide diuretics on the gene expression of endothelial nitric oxide synthase and endothelin-1 in the spontaneous hypertensive rats. Zhongguo Yaolixue Tongbao 22:552-555 (Pubitemid 44229533)
71. Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L (2003) Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 17:2328-2330 (Pubitemid 39561482)
72. Heptinstall S, Fox S, Crawford J, Hawkins M (1986) Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin. Thromb Res 42:215-223 (Pubitemid 16073427)
73. Higaki Y, Hirshman MF, Fujii N, Goodyear LJ (2001) Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 50:241-247 (Pubitemid 32127278)
74. Hogg N (2002) The biochemistry and physiology of S-nitrosothiols. Annu Rev Pharmacol Toxicol 42:585-600
75. Hosoya M, Ohashi J, Sawada A, Takaki A, Shimokawa H (2010) Combination therapy with olmesartan and azelnidipine improves EDHF-mediated responses in diabetic apolipoprotein E-deficient mice. Circ J 74:798-806
76. Huang PL (2004) Nitric oxide and cerebral ischemic preconditioning. Cell Calcium 36:323-329
77. Huang Z, Huang PL, Ma J, Meng W, Ayata C, Fishman MC, Moskowitz MA (1996) Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab 16:981-987 (Pubitemid 26292066)
78. Huang Y, Cheng Y, Wu J, Li Y, Xu E, Hong Z, Li Z, Zhang W, Ding M, Gao X, Fan D, Zeng J, Wong K, Lu C, Xiao J, Yao C, CvAfSISPc Investigators (2008) Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study. Lancet Neurol 7:494-499
79. Ishrat T, Sayeed I, Atif F, Stein DG (2009) Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Brain Res 1257:94-101
80. Ishrat T, Sayeed I, Atif F, Hua F, Stein DG (2010) Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases. Exp Neurol 226:183-190
81. Ito T, Yamakawa H, Bregonzio C, Terrón JA, Falcón-Neri A, Saavedra JM (2002) Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33:2297-2303 (Pubitemid 35014646)
82. Ito U, Nagasao J, Kawakami E, Oyanagi K (2007) Fate of disseminated dead neurons in the cortical ischemic penumbra: ultrastructure indicating a novel scavenger mechanism of microglia and astrocytes. Stroke 38:2577-2583 (Pubitemid 47329640)
83. Ito D, Ito O, Mori N, Muroya Y, Cao PY, Takashima K, Kanazawa M, Kohzuki M (2010) Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats. J Hypertens 28:2278-2288
84. Kacimi R, Giffard RG, Yenari MA (2011) Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAKSTAT and JNK stress kinase pathways. J Inflamm (Lond) 8:7
85. Kambayashi J, Liu Y, Sun B, Shakur Y, Yoshitake M, Czerwiec F (2003) Cilostazol as a unique antithrombotic agent. Curr Pharm Des 9:2289-2302 (Pubitemid 37236353)
86. Kaposzta Z, Baskerville PA, Madge D, Fraser S, Martin JF, Markus HS (2001) L-arginine and S-nitrosoglutathione reduce embolization in humans. Circulation 103:2371-2375 (Pubitemid 32448802)
87. Kaposzta Z, Clifton A, Molloy J, Martin JF, Markus HS (2002) S-nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty. Circulation 106:3057-3062 (Pubitemid 35440288)
88. Kasahara Y, Taguchi A, Uno H, Nakano A, Nakagomi T, Hirose H, Stern DM, Matsuyama T (2010) Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia. Brain Res 1340:70-80
89. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18:687-697 (Pubitemid 28041905)
90. Khaidakov M, Szwedo J, Mitra S, Ayyadevara S, Dobretsov M, Lu J, Mehta JL (2010) Anti-angiogenic and anti-mitotic effects of aspirin in hypoxia-reoxygenation modulation of LOX-1-NADPH oxidase axis as potential mechanism. J Cardiovasc Pharmacol 56:635-641
91. Khan M, Sekhon B, Giri S, Jatana M, Gilg AG, Ayasolla K, Elango C, Singh AK, Singh I (2005) S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J Cereb Blood Flow Metab 25:177-192 (Pubitemid 40171200)
92. Khan M, Jatana M, Elango C, Paintlia AS, Singh AK, Singh I (2006) Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15:114-124 (Pubitemid 44175884)
93. Kim HH, Liao JK (2008) Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol 28:s39-s42
94. Kim HH, Sawada N, Soydan G, Lee HS, Zhou Z, Hwang SK, Waeber C, Moskowitz MA, Liao JK (2008a) Additive effects of statin and dipyridamole on cerebral blood flow and stroke protection. J Cereb Blood Flow Metab 28:1285-1293 (Pubitemid 351896647)
95. Kim KH, Moriarty K, Bender JR (2008b) Vascular cell signaling by membrane estrogen receptors. Steroids 73:864-869
96. Kobayashi N, Yoshida K, Nakano S, Ohno T, Honda T, Tsubokou Y, Matsuoka H (2006) Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts. Hypertension 47:671-679 (Pubitemid 43740237)
97. Kobayashi T, Kawamata T, Shibata N, Okada Y, Kobayashi M, Hori T (2009) Angiotensin II type 1 receptor blocker telmisartan reduces cerebral infarct volume and peri-infarct cytosolic phospholipase A(2) level in experimental stroke. J Neurotrauma 26:2355-2364
98. Kuhn W, Müller T, Bttner T, Gerlach M (1995) Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia. Stroke 26:1959-1960
99. Kukreja RC, Ockaili R, Salloum F, Yin C, Hawkins J, Das A, Xi L (2004) Cardioprotection with phosphodiesterase-5 inhibition - a novel preconditioning strategy. J Mol Cell Cardiol 36:165-173 (Pubitemid 38202344)
100. Kuroki I, Miyazaki T, Mizukami I, Matsumoto N, Matsumoto I (2004) Effect of sodium nitroprusside on ischemia-reperfusion injuries of the rat liver. Hepatogastroenterology 51:1404-1407 (Pubitemid 38987493)
101. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG (2003) Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111:1201-1209 (Pubitemid 36519937)
102. Laufs U, Gertz K, Dirnagl U, Böhm M, Nickenig G, Endres M (2002) Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice. Brain Res 942:23-30 (Pubitemid 34597065)
103. Lee W, Ou H, Hsu W, Chou M, Tseng J, Hsu S, Tsai K, Sheu W (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells. J Vasc Surg 52:1290-1300
104. Li X, Wang P, Xu X, Wang Y, Xia Y, Wang D (2009) Simvastatin increases the activity of endothelial nitric oxide synthase via enhancing phosphorylation. J Huazhong Univ Sci Technol Med Sci 29:286-290
105. Littleton-Kearney MT, Gaines JM, Callahan KP, Murphy SJ, Hurn PD (2005a) Effects of estrogen on platelet reactivity after transient forebrain ischemia in rats. Biol Res Nurs 7:135-145 (Pubitemid 44289592)
106. Littleton-Kearney MT, Klaus JA, Hurn PD (2005b) Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat. J Cereb Blood Flow Metab 25:421-426
107. Lu YZ, Lin CH, Cheng FC, Hsueh CM (2005) Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci Lett 373:159-164 (Pubitemid 39572981)
108. Lu DY, Liou HC, Tang CH, Fu WM (2006) Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha. Biochem Pharmacol 72:992-1000 (Pubitemid 44374459)
109. Magen E, Viskoper JR, Mishal J, Priluk R, London D, Yosefy C (2005) Effects of low-dose aspirin on BP and endothelial function of treated hypertensive hypercholesterolaemic subjects. J Hum Hypertens 19:667-673 (Pubitemid 43118088)
110. Maggard MA, Ke B, Wang T, Kaldas F, Seu P, Busuttil RW, Imagawa DK (1998) Effects of pravastatin on chronic rejection of rat cardiac allografts. Transplantation 65:149-155 (Pubitemid 28099203)
111. Martínez-Murillo R, Fernández AP, Serrano J, Rodrigo J, Salas E, Mourelle M, Martínez A (2007) The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model. Neurosci Lett 415:149-153
112. Mason RP, Kubant R, Heeba G, Jacob RF, Day CA, Medlin YS, Funovics P, Malinski T (2008) Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction. Pharm Res 25:1798-1806
113. McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY (2004) A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol 172:2903-2908 (Pubitemid 38263676)
114. McNeill AM, Kim N, Duckles SP, Krause DN, Kontos HA (1999) Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30:2186-2190 (Pubitemid 29473269)
115. McNeill AM, Zhang C, Stanczyk FZ, Duckles SP, Krause DN (2002) Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke 33:1685-1691 (Pubitemid 34619979)
116. Miura T, Ogawa T, Iwamoto T, Shimamoto K, Iimura O (1992) Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning. Circulation 86:979-985
117. Morikawa E, Moskowitz MA, Huang Z, Yoshida T, Irikura K, Dalkara T (1994) L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25:429-435
118. Nakajima K, Honda S, Tohyama Y, Imai Y, Kohsaka S, Kurihara T (2001) Neurotrophin secretion from cultured microglia. J Neurosci Res 65:322-331 (Pubitemid 32727034)
119. Nakamura T, Houchi H, Minami A, Sakamoto S, Tsuchiya K, Niwa Y, Minakuchi K, Nakaya Y (2001) Endothelium-dependent relaxation by cilostazol, a phosphodiesteras III inhibitor, on rat thoracic aorta. Life Sci 69:1709-1715 (Pubitemid 32785280)
120. Nakamura T, Tsutsumi Y, Shimizu Y, Uchiyama S (2010) Renin-angiotensin system blockade safely reduces BP in patients with minor ischemic stroke during the acute phase. J Stroke Cerebrovasc Dis 19:435-440
121. Neumann J, Gunzer M, Gutzeit HO, Ullrich O, Reymann KG, Dinkel K (2006) Microglia provide neuroprotection after ischemia. FASEB J 20:714-716 (Pubitemid 46671191)
122. Nonaka Y, Koumura A, Hyakkoku K, Shimazawa M, Yoshimura S, Iwama T, Hara H (2009) Combination treatment with normobaric hyperoxia and cilostazol protects mice against focal cerebral ischemia-induced neuronal damage better than each treatment alone. J Pharmacol Exp Ther 330:13-22
123. Novensa L, Selent J, Pastor M, Sandberg K, Heras M, Dantas AP (2010) Equine estrogens impair nitric oxide production and endothelial nitric oxide synthase transcription in human endothelial cells compared with the natural 17{beta}-estradiol. Hypertension 56:405-411
124. Numagami Y, Zubrow AB, Mishra OP, Delivoria-Papadopoulos M (1997) Lipid free radical generation and brain cell membrane alteration following nitric oxide synthase inhibition during cerebral hypoxia in the newborn piglet. J Neurochem 69:1542-1547 (Pubitemid 27406955)
125. Oh YT, Lee JY, Lee J, Lee JH, Kim JE, Ha J, Kang I (2010) Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells. Neurosci Lett 474:148-153
126. Oprisiu-Fournier R, Faure S, Mazouz H, Boutitie F, Serot JM, Achard JM, Godefroy O, Hanon O, Temmar M, Albu A, Strandgaard S, Wang J, Black SE, Fournier A (2009) Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors? Expert Rev Neurother 9:1289-1305
127. Ota H, Eto M, Kano MR, Ogawa S, Iijima K, Akishita M, Ouchi Y (2008) Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler Thromb Vasc Biol 28:1634-1639
128. Otsuki M, Saito H, Xu X, Sumitani S, Kouhara H, Kurabayashi M, Kasayama S (2001) Cilostazol represses vascular cell adhesion molecule-1 gene transcription via inhibiting NF-kappaB binding to its recognition sequence. Atherosclerosis 158:121-128 (Pubitemid 32735475)
129. Ou H, Lee W, Lee S, Huang C, Chiu T, Tsai K, Hsu W, Sheu W (2010) Ellagic acid protects endothelial cells from oxidized low-density lipoprotein-induced apoptosis by modulating the PI3K/Akt/eNOS pathway. Toxicol Appl Pharmacol 248:134-143
130. Papoutsi Z, Kassi E, Chinou I, Halabalaki M, Skaltsounis L, Moutsatsou P (2008) Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483. Br J Nutr 99:715-722 (Pubitemid 351351624)
131. Pari L, Sivasankari R (2008) Effect of ellagic acid on cyclosporine A-induced oxidative damage in the liver of rats. Fundam Clin Pharmacol 22:395-401
132. Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, Lee WS, Hong KW (2005) Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther 312:1241-1248
133. Pasini FL, Guideri F, Ferber D, Galgano G, Bianchi A, Isidori S, De Giorgi L, Petri S, Capecchi PL, Di Perri T (1996) Pharmacological preconditioning of ischemic heart disease by low-dose dipyridamole. Int J Cardiol 56:17-27 (Pubitemid 26313307)
134. Paumelle R, Blanquart C, Briand O, Barbier O, Duhem C, Woerly G, Percevault F, Fruchart JC, Dombrowicz D, Glineur C, Staels B (2006) Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway. Circ Res 98:361-369
135. Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan L, Pant R, Menon VP, Otani H, Maulik N (2007) Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat. J Mol Cell Cardiol 42:508-516 (Pubitemid 46349117)
136. Pérez FR, Venegas F, González M, Andrés S, Vallejos
137. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C (2009) Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 8:48-56
138. Priyadarsini K, Khopde S, Kumar S, Mohan H (2002) Free radical studies of ellagic acid, a natural phenolic antioxidant. J Agric Food Chem 50:2200-2206 (Pubitemid 34260032)
139. Ricchiuti V, Lian CG, Oestreicher EM, Tran L, Stone JR, Yao T, Seely EW, Williams GH, Adler GK (2009) Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats. J Endocrinol 200:75-84
140. Richard V, Thuillez C (1999) Improvement of endothelial function with the fixed low-dose perindopril-indapamide combination. Eur Heart J Suppl 1:L38-L43 (Pubitemid 29348593)
141. Richardson G, Benjamin N (2002) Potential therapeutic uses for S-nitrosothiols. Clin Sci (Lond) 102:99-105 (Pubitemid 34177806)
142. Riksen NP, Oyen WJ, Ramakers BP, Van den Broek PH, Engbersen R, Boerman OC, Smits P, Rongen GA (2005) Oral therapy with dipyridamole limits ischemia-reperfusion injury in humans. Clin Pharmacol Ther 78:52-59 (Pubitemid 40956931)
143. Rosanio S, Ye Y, Atar S, Rahman AM, Freeberg SY, Huang MH, Uretsky BF, Birnbaum Y (2006) Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. Cardiovasc Drugs Ther 20:27-36
144. Rossi J, Rouleau L, Tardif JC, Leask RL (2010) Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress. Life Sci 87:92-99
145. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW, for the PRoFESS Study Group (2008) Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med 359:1238-1251
146. Salom JB, Ortí M, Centeno JM, Torregrosa G, Alborch E (2000) Reduction of infarct size by the NO donors sodium nitroprusside and spermine/NO after transient focal cerebral ischemia in rats. Brain Res 865:149-156 (Pubitemid 30255992)
147. Sanz-Rosa D, Oubiña MP, Cediel E, De las Heras N, Aragoncillo P, Balfagón G, Cachofeiro V, Lahera V (2005) Eplerenone reduces oxidative stress and enhances eNOS in SHR: vascular functional and structural consequences. Antioxid Redox Signal 7: 1294-1301 (Pubitemid 41232527)
148. Sare GM, Gray LJ, Bath PM (2008) Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. Eur Heart J 29:2031-2041
149. Sayeed I, Guo Q, Hoffman SW, Stein DG (2006) Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 47:381-389
150. Sayeed I, Wali B, Stein DG (2007) Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 25:151-159 (Pubitemid 47290443)
151. Schneck MJ (2009) Understanding the PRoFESS study for secondary stroke prevention. Curr Treat Options Cardiovasc Med 11:221-231
152. Schneider JC, El Kebir D, Chéreau C, Lanone S, Huang XL, De Buys Roessingh AS, Mercier JC, Dall'Ava-Santucci J, Dinh-Xuan AT (2003) Involvement of Ca2+/calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 284:H2311-H2319 (Pubitemid 36622446)
153. Serebruany V, Sani Y, Eisert C, Schevchuck A, Fong A, Hanley D (2011) Effects of aggrenox and aspirin on plasma endothelial nitric oxide synthase and oxidised low-density lipoproteins in patients after ischaemic stroke. The AGgrenox versus aspirin therapy evaluation (AGATE) biomarker substudy. Thromb Haemost 105:81-87
154. Serrano J, Fernández AP, Martínez-Murillo R, Alonso D, Rodrigo J, Salas E, Mourelle M, Martínez A (2007) The nitric oxide donor LA 419 decreases ischemic brain damage. Int J Mol Med 19:229-236
155. Seujange Y, Eiam-Ong S, Tirawatnapong T (2008) Role of angiotensin II on dihydrofolate reductase, GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion. Am J Nephrol 28:692-700 (Pubitemid 351832458)
156. Shimokawa T, Smith WL (1992) Prostaglandin endoperoxide synthase. The aspirin acetylation region. J Biol Chem 267:12387-12392
157. Shinohara Y, Gotoh F, Tohgi H, Hirai S, Terashi A, Fukuuchi Y, Otomo E, Itoh E, Matsuda T, Sawada T, Yamaguchi T, Nishimaru K, Ohashi Y (2008) Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study. Cerebrovasc Dis 26:63-70 (Pubitemid 351931422)
158. Shinohara Y, Katayama Y, Uchiyama S, Yamaguchi T, Handa S, Matsuoka K, Ohashi Y, Tanahashi N, Yamamoto H, Genka C, Kitagawa Y, Kusuoka H, Nishimaru K, Tsushima M, Koretsune Y, Sawada T, Hamada C, CSPS 2 Group (2010) Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. Lancet Neurol 9:959-968
159. Simoncini T, Mannella P, Fornari L, Caruso A, Varone G, Garibaldi S, Genazzani AR (2004) Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab 89: 4594-4600 (Pubitemid 39244475)
160. Son HY, Han HS, Jung HW, Park YK (2009) Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia. J Pharmacol Sci 109:368-379
161. Sprague AH, Khalil RA (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78:539-552
162. Stagliano NE, Dietrich WD, Prado R, Green EJ, Busto R (1997) The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat. Brain Res 759:32-40 (Pubitemid 27286341)
163. Stuehr D (1999) Mammalian nitric oxide synthases. Biochim Biophys Acta 1411:217-230
164. Stüve O, Youssef S, Steinman L, Zamvil SS (2003) Statins as potential therapeutic agents in neuroinflammatory disorders. Curr Opin Neurol 16:393-401 (Pubitemid 36688309)
165. Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti A (1997) Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension 30:1606-1612 (Pubitemid 27528112)
166. Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, Salvetti A (2001) Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension 37:943-948 (Pubitemid 32221618)
167. Tamura T, Jamous MA, Kitazato KT, Yagi K, Tada Y, Uno M, Nagahiro S (2009) Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J Hypertens 27:1284-1292
168. Taubert D, Berkels R, Grosser N, Schröder H, Gründemann D, Schömig E (2004) Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action. Br J Pharmacol 143:159-165 (Pubitemid 39280035)
169. Thai HM, Do BQ, Tran TD, Gaballa MA, Goldman S (2006) Aldosterone antagonism improves endothelial-dependent vasorelaxation in heart failure via upregulation of endothelial nitric oxide synthase production. J Card Fail 12:240-245
170. Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I (1999) Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30:1409-1416 (Pubitemid 29296069)
171. Thompson PD, Zimet R, Forbes WP, Zhang P (2002) Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 90:1314-1319 (Pubitemid 35449476)
172. Toba H, Nakagawa Y, Miki S, Shimizu T, Yoshimura A, Inoue R, Asayama J, Kobara M, Nakata T (2005) Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the BP-lowering effects of amlodipine and manidipine. Hypertens Res 28:689-700 (Pubitemid 41601043)
173. Török J, L'upták I, Matúsková J, Pechánová O, Zicha J, Kunes J, Simko F (2007) Comparison of the effect of simvastatin, spironolactone and L-arginine on endothelial function of aorta in hereditary hypertriglyceridemic rats. Physiol Res 56(Suppl 2):S33-S40
174. Trauernicht AK, Sun H, Patel KP, Mayhan WG (2003) Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats. Stroke 34:2698-2703 (Pubitemid 37392770)
175. Trocha M, Merwid-Lad A, Szuba A, Chlebda E, Pieśniewska M, Sozański T, Szelag A (2010) Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver. Pharmacol Rep 62:343-351
176. Turrin NP, Rivest S (2006) Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity. J Neurosci 26:143-151 (Pubitemid 43089527)
177. Uchiyama S, Demaerschalk BM, Goto S, Shinohara Y, Gotoh F, Stone WM, Money SR, Kwon SU (2009) Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis 18:482-490
178. Vásquez-Vivar J, Kalyanaraman B, Martásek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95:9220-9225 (Pubitemid 28506212)
179. Venkatesh PK, Pattillo CB, Branch B, Hood J, Thoma S, Illum S, Pardue S, Teng X, Patel RP, Kevil CG (2010) Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc Res 85:661-670
180. Wang N, Minatoguchi S, Chen XH, Arai M, Uno Y, Lu C, Misao Y, Nagai H, Takemura G, Fujiwara H (2004) Benidipine reduces myocardial infarct size involving reduction of hydroxyl radicals and production of protein kinase C-dependent nitric oxide in rabbits. J Cardiovasc Pharmacol 43:747-757 (Pubitemid 38679595)
181. Wang Q, Tang XN, Yenari MA (2007) The inflammatory response in stroke. J Neuroimmunol 184:53-68 (Pubitemid 46365991)
182. Wang J, Jiang C, Li X, Liu C, Cheng N, Hao Y (2009) The protective mechanism of progesterone on blood-brain barrier in cerebral ischemia in rats. Brain Res Bull 79:426-430
183. Wang J, Jiang C, Liu C, Li X, Chen N, Hao Y (2010) Neuroprotective effects of progesterone following stroke in aged rats. Behav Brain Res 209:119-122
184. Willmot M, Gray L, Gibson C, Murphy S, Bath PM (2005) A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12:141-149 (Pubitemid 40432134)
185. Wolfrum S, Grimm M, Heidbreder M, Dendorfer A, Katus HA, Liao JK, Richardt G (2003) Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol 41:474-480 (Pubitemid 36255308)
186. Wood PL (1995) Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol Res 17:242-248
187. Wung BS, Cheng JJ, Shyue SK, Wang DL (2001) NO modulates monocyte chemotactic protein-1 expression in endothelial cells under cyclic strain. Arterioscler Thromb Vasc Biol 21:1941-1947 (Pubitemid 34219745)
188. Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, Münzel T, Förstermann U, Li H (2010) Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 335:149-154
189. Yamakawa H, Jezova M, Ando H, Saavedra JM (2003) Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 23:371-380 (Pubitemid 36307581)
190. Yamamoto E, Nakamura T, Kataoka K, Tokutomi Y, Dong YF, Fukuda M, Nako H, Yasuda O, Ogawa H, Kim-Mitsuyama S (2010) Nifedipine prevents vascular endothelial dysfunction in a mouse model of obesity and type 2 diabetes, by improving eNOS dysfunction and dephosphorylation. Biochem Biophys Res Commun 403:258-263
191. Yamashita T, Kawashima S, Ozaki M, Rikitake Y, Hirase T, Inoue N, Hirata K, Yokoyama M (2001) A calcium channel blocker, benidipine, inhibits intimal thickening in the carotid artery of mice by increasing nitric oxide production. J Hypertens 19:451-458 (Pubitemid 32195381)
192. Yang XP, Liu YH, Shesely EG, Bulagannawar M, Liu F, Carretero OA (1999) Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension 34:24-30 (Pubitemid 29325714)
193. Yasuda Y, Tateishi N, Shimoda T, Satoh S, Ogitani E, Fujita S (2004) Relationship between S100beta and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia. Brain Res 1021:20-31 (Pubitemid 39158653)
194. Ye Y, Lin Y, Atar S, Huang MH, Perez-Polo JR, Uretsky BF, Birnbaum Y (2006) Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. Am J Physiol Heart Circ Physiol 291:H1158-H1169 (Pubitemid 44343659)
195. Ye Y, Lin Y, Perez-Polo R, Huang MH, Hughes MG, McAdoo DJ, Manickavasagam S, Uretsky BF, Birnbaum Y (2007) Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. Am J Physiol Heart Circ Physiol 293:H813-H818 (Pubitemid 47105146)
196. Ye Y, Long B, Qian J, Perez-Polo JR, Birnbaum Y (2011) Dipyridamole with low-dose aspirin augments the infarct size-limiting effects of simvastatin. Cardiovasc Drugs Ther 24:391-399
197. Yemisci M, Ay H, Kocaefe C, Qui J, Topalkara K, Ozgüç M, Kirazli S, Ozcebe O, Moskowitz MA, Dalkara T (2008) Statin potentiates human platelet eNOS activity without enhancing eNOS mRNA and protein levels. Cerebrovasc Dis 26:190-198
198. Yenari MA, Xu L, Tang XN, Qiao Y, Giffard RG (2006) Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke 37:1087-1093
199. Zerr-Fouineau M, Chataigneau M, Blot C, Schini-Kerth VB (2007) Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors. FASEB J 21:265-273 (Pubitemid 46052565)
200. Zhang X, Hintze TH (1998) Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 97:576-580 (Pubitemid 28090687)
201. Zhang Z, Hamilton S, Stewart C, Strother A, Teel R (1993) Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res 13:2341-2346 (Pubitemid 24036373)
202. Zhang F, White JG, Iadecola C (1994) Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 14:217-226 (Pubitemid 24064434)
203. Zhuang P, Ji H, Zhang YH, Min ZL, Ni QG, You R (2010) ZJM-289, a novel nitric oxide donor, alleviates the cerebral ischaemic-reperfusion injury in rats. Clin Exp Pharmacol Physiol 37:e121-e127